Riikka Huovinen

Prospective evaluation of planar bone scintigraphy, SPECT, SPECT/CT, ¹⁸F-NaF PET/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial

Ivan Jambor, Anna Kuisma, Susan Ramadan et al. · Acta Oncologica · 2015 · 196 citations · Full text

Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells In Vivo and In Vitro

Anni Wärri, Riikka Huovinen, Antti Laine et al. · JNCI Journal of the National Cancer Institute · 1993 · 195 citations

Effect of Adjuvant Trastuzumab for a Duration of 9 Weeks vs 1 Year With Concomitant Chemotherapy for Early Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Heikki Joensuu, Judith Fraser, Hans Wildiers et al. · JAMA Oncology · 2018 · 145 citations · Full text

Adjuvant Capecitabine, Docetaxel, Cyclophosphamide, and Epirubicin for Early Breast Cancer: Final Analysis of the Randomized FinXX Trial

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Riikka Huovinen et al. · Journal of Clinical Oncology · 2011 · 116 citations · Full text

Quality of life and physical performance and activity of breast cancer patients after adjuvant treatments

Heidi Penttinen, Tiina Saarto, Pirkko Kellokumpu‐Lehtinen et al. · Psycho-Oncology · 2010 · 111 citations